vitamin · for chronic inflammation
Vitamin D
Steers your immune system away from its inflammatory setting and toward its calming one.
Say that in clinical terms
Vitamin D modulates both innate and adaptive immune responses, shifting the balance from pro-inflammatory Th1/Th17 to anti-inflammatory Th2/Treg responses. It suppresses NF-kB, reduces TNF-alpha, IL-6, and CRP, and enhances anti-inflammatory IL-10.
How strong is the research?
A pooled analysis of 24 trials found no reduction in the main blood marker of inflammation.
3 papers read, 2 supporting, 1 against.
Tested as: vitamin D supplementation — D3 versus D2 not confirmed in any cited trial
Who was studied: Mostly COVID-19 patients and acute infection, per the cited source.
How much to take
daily with a fat-containing meal
2000–4000 IU
Vitamin D deficiency is strongly associated with elevated inflammatory markers. Test and optimize levels.
Before you take it
- NIH ODS Tolerable Upper Intake Level (UL) for adults aged 19+ is 4,000 IU/day
- Drug interaction: thiazide diuretics combined with vitamin D3 increase risk of hypercalcemia by reducing urinary calcium excretion
- Drug interaction: anticonvulsants (phenobarbital, phenytoin) induce CYP enzymes that accelerate vitamin D catabolism, reducing circulating levels and therapeutic efficacy
- Drug interaction: bile acid sequestrants (cholestyramine, colestipol) impair absorption of fat-soluble vitamins including vitamin D3; doses should be separated
- Drug interaction: orlistat inhibits dietary fat absorption and reduces vitamin D3 absorption; monitoring of vitamin D status is recommended with concurrent use
- Drug interaction: corticosteroids (e.g., prednisone, dexamethasone) impair vitamin D metabolism and reduce intestinal calcium absorption, potentially antagonizing vitamin D effects
- Drug interaction: vitamin D3 at high doses may alter CYP3A4 activity and potentially affect pharmacokinetics of statins metabolized by that pathway (atorvastatin, lovastatin, simvastatin); clinical significance is modest
- Contraindication: pre-existing hypercalcemia or hypercalciuria — supplementation without medical supervision is contraindicated
- Caution: granulomatous diseases (sarcoidosis, tuberculosis, histoplasmosis, some lymphomas) produce unregulated endogenous calcitriol independent of serum 25(OH)D; exogenous vitamin D supplementation can precipitate severe hypercalcemia — requires endocrinology oversight
- Caution: impaired renal function reduces conversion of vitamin D to active calcitriol and impairs urinary calcium excretion, increasing toxicity risk; monitoring is required
- Caution: primary hyperparathyroidism — calcium-vitamin D axis is dysregulated; supplementation requires specialist oversight
- Toxicity signs at sustained supra-UL doses: hypercalcemia, hypercalciuria, nausea, polyuria, weakness, nephrolithiasis, soft-tissue calcification, and irreversible renal damage
- Users experiencing chronic systemic inflammation may have underlying granulomatous disease (e.g., sarcoidosis) in which vitamin D supplementation can precipitate dangerous hypercalcemia due to unregulated endogenous calcitriol production; medical evaluation for cause of inflammation is warranted before supplementing
When to take it
Best taken: morning
What we make of it
The citation is a review of vitamin D and COVID-19 severity.
The detail
The identifier resolves to a review of vitamin D in COVID-19, not inflammation in generally healthy adults. Using it here stretches it well past what it examined.